Since its establishment in May 2000, microbio has been adhering to the concept of active innovation, focusing on the research and development of high-end products for new medicines and medical care, and gradually forming a biotechnology enterprise group with “innovation” as its core. In-depth development in new drug research and development, organic agriculture and biotechnology venture capital. While achieving corporate development and enhancing shareholders' rights, we also fulfill our corporate social responsibility and care for our lives.
In terms of new drug research and development, Chemo young and Herbiron have obtained the new drug certificates approved by the Ministry of Health and Welfare, and have successfully developed a variety of microbial pharmaceutical technology platforms, and have repeatedly made major breakthroughs in the field of biotechnology. The Microbio has received many awards and professional awards such as Biomedical Quality Award and Biomedical Innovation Award. At the same time, Microbio continues to uphold professional and rigorous R&D management, combined with the first-class R&D team, to develop high-quality medical and health care products, including Tien Chun Boo, top quality enzyme drinks and Lee Herb series products and other patented leading products.
The Microbio has developed into a holding company and diversified its business model. The Group's members include "Oneness Biotech", which develops global innovative drugs, "Fountain Biopharma", which has the world's largest all-human antibody library, and "Cotton Field Organic", which promotes organic businesses. The "Diamond Biofund" fund invested in the biomedical industry and Microbio (Shanghai) established in the mainland, etc., all members of the holding company have successively created core values in different fields of biotechnology.